In vitro efficacy of antimicrobial wafers against methicillin-resistant Staphylococcus aureus

Therapeutic Delivery

Volumn 3, Issue 4, 2012, Pages 443-455

  Labovitiadi, Olga ^a   Lamb, Andrew J ^a   Matthews, Kerr H ^a  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CHLORHEXIDINE GLUCONATE; KARAYA GUM; NEOMYCIN; POVIDONE IODINE; SULFADIAZINE SILVER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; COOLING; DISK DIFFUSION; DRUG DELIVERY SYSTEM; FLOW KINETICS; FRANZ DIFFUSION; FREEZE DRYING; GEL; IN VITRO STUDY; KARAYA WAFER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; POROSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SIMULATION; SWELLING; TEMPERATURE; VISCOSITY; WOUND FLUID;

EID: 84859247898     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.27     Document Type: Article

References (38)

1. Keast DH, Orsted H. The basic principles of wound care. Ostomy Wound Manage. 44(8), 24-28 (1998).
2. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas, DW. A review of the microbiology and antibiotic usage and resistance in chronic skin wounds. J. Antimicrob.. Chemother. 55(2), 143-149 (2005). (Pubitemid 40331137)
3. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin. Microb. Rev. 14(2), 244-269 (2001). (Pubitemid 32294670)
4. Weber JD, Raasch R, Rutala AR. Nosocomial infections in the ICU: the growing importance of antibiotic-resistance pathogens. Chest 115(3), 34-41 (1999).
5. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Anns. Intern. Med. 134(4), 298-314 (2001). (Pubitemid 32163954)
6. Joint Formulary Committee. British National Formulary. Pharmaceutical Press, London, UK (2009).
7. Lee ARC, Leem H, Lee J, Park KC. Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. Biomaterials 26(22), 4670-4676 (2005). (Pubitemid 40269284)
8. NHS. The UK Drug Tariff. The Stationary Office, London, UK (2007).
9. Spann CT, Tutrone WD, Weinberg JM, Scheinfeld N, Ross B. Topical antibacterial agents for wound care: a primer. Dermatol. Surg. 29(6), 620-626 (2003). (Pubitemid 36702448)
10. Mann A, Tighe BJ. Wound healing studies and interfacial phenomena: use and relevance of the corneal model. In: Advanced Wound Repair Therapies. Farrar D (Ed.). Woodhead Publishing, Oxford, UK, 284-320 (2011).
11. Matthews KH. Drug delivery dressings. In: Advanced Wound Repair Therapies. Farrar D (Ed.). Woodhead Publishing, Oxford, UK 361-394 (2011).
12. Boateng SJ, Matthews KH, Stevens HNE, Eccleston GM. Wound healing dressings and drug delivery systems: a review, J. Pharm. Sci. 97(8), 2892-2923 (2007).
13. Davis S, Gil J, Valdes J, Perez J, Rivas Y. The effects of wound dressings as barriers to Pseudomonas aeruginosa colonization of full thickness wounds using a well established porcine wound model. J. Am. Acad. Dermatol. 60(Suppl. 1), AB110 (2009).
14. Spann CT, Taylor S, Weinberg J. Topical antimicrobial agents in dermatology. Dis. Mon. 50(7), 407-421 (2004).
15. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am. J. Surg. 187(5A), 65S-70S (2004). (Pubitemid 38625990)
16. Matthews KH, Stevens HNE, Auffret AD, Humphrey MJ, Eccleston GM. Lyophilised wafers as a drug delivery system for wound healing containing methylcellulose as a viscosity modifier. Int. J. Pharm. 289(1-2), 51-62 (2005). (Pubitemid 40093540)
17. Matthews KH, Stevens HNE, Auffret AD, Humphrey MJ, Eccleston GM. Gamma-irradiation of lyophilised wound healing wafers. Int. J. Pharm. 313(1-2), 78-86 (2006).
18. Matthews KH, Stevens HNE, Auffret AD, Humphrey MJ, Eccleston GM. Formulation, stability and thermal analysis of lyophilised wound healing wafers containing an insoluble MMP-3 inhibitor and a non-ionic surfactant. Int. J. Pharm. 356(1-2), 110-120 (2006).
19. Bromberg LE, Buxton DK, Friden PM. Novel periodontal drug delivery system for treatment of periodontitis. J. Control. Release 71(3), 251-259 (2001). (Pubitemid 32276045)
20. Labovitiadi O, Matthews KH. Rheological investigation of some common polymer gels and their synergistic combinations, J. Pharm. Pharma. 60(1), 42-105 (2008).
21. Turnidge JD, Bell JM. Antimicrobial susceptibility on solid media. In: Antibiotics in Laboratory Medicine. Lorian V (Ed.). Lippincott Williams & Wilkens, Philadelphia, PA, USA (2005).
22. Clough G, Noble M. Microdialysis - a model for studying chronic wounds. Int. J. Low. Extrem. Wounds 2(4), 233-239 (2003).
23. Eming SA, Smola-Hess S, Kurschat P, Hirch D, Krieg T, Smola H. A novel property of povidine-iodine: inhibition of excessive protease levels in chronic non-healing wounds. J. Invest. Derm. 126(12), 2731-2733 (2006). (Pubitemid 44764062)
24. Noda Y, Satoshi F. Critical role of water diffusion into matrix in external use iodine preparations. Int. J. Pharm. 394(1-2), 85-91 (2010).
25. Atemnkeng MA, Plaizier-Vercammen J, Schuermans A. Comparison of free and bound iodine and iodine species as a function of the dilution of three commercial povidine-iodine formulations and their microbicidal activity. Int. J. Pharm. 317(2), 161-166 (2006). (Pubitemid 44202256)
26. Hamilton-Miller JMT, Shah S. A microbiological assessment of silver fusidate, a novel topical antimicrobial agent. Int. J. Antimicrob. Agents 7(2), 97-99 (1996). (Pubitemid 26276689)
27. White JR, Cooper R. Silver sulphadiazine: a review of the evidence. Wounds UK 1(2), 51-62 (2005) .
28. Tsipouras N, Rix JC, Brady HP. Solubility of silver sulfadiazine in physiological media and relevance to treatment of thermal burns with silver sulfadiazine cream. Clin. Chem. 41(1), 87-91 (1995).
29. Cotton FA, Wilkinson G. Advanced Inorganic Chemistry - A Comprehensive Text (4th Edition). Wiley Interscience, New York, NY, USA (1980).
30. Gallant-Behm CL, Yin HQ, Liu S. Comparison of in vitro diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy. Wound Repair Regen. 13(4), 412-421 (2005). (Pubitemid 41060423)
31. Stinecipher J, Shah J. Percutaneous permeation of the meta, ortho and para isomers of N,N-diethyltoluamide. Int J. Pharm. 160(1), 31-41 (1998). (Pubitemid 28059927)
32. Gillet A, Evrard B, Piel G. Liposomes and parameters affecting their skin penetration behaviour. J. Drug Deliv. Sci. Tech. 21(1), 35-42 (2011).
33. Messager S, Goddard PA, Dettmar PW, Maillard JY. Determination of the antibacterial efficacy of several antiseptics tested on skin by an ex vivo test. J. Med. Microbiol. 50(3), 284-292 (2001). (Pubitemid 32173939)
34. Talbert AM, Tranter GE, Holmes E, Francis PL. Determination of drug-plasma protein binding kinetics and equilibria by chromatographic profiling: exemplification of the method using l-tryptophan and albumin. Anal. Chem. 74(2), 446-452 (2002). (Pubitemid 34072713)
35. Otagiri M. A molecular functional study on the interactions of drugs with plasma proteins. Drug Metab. Pharmcokinet. 20(5), 309-323 (2005).
36. Doremus HR, Johnson P. The interaction of small ions with proteins from electrical conductance and transference experiments. J. Phys. Chem. 62(2), 203-209 (1958).
37. Keswani N, Choudhary S, Kishore N. Interaction of weakly bound neomycin and lincomycin with bovine and human serum albumin: biophysical approach. J. Biochem. 148(1), 71-84 (2010).
38. Gupta A, Maynes M, Silver S. Effects of halides on plasmid-mediated silver resistance in Escherichia coli. Appl. Environ. Microbiol. 64(12), 5042-5045 (1998). (Pubitemid 28557883)